Work

Additional file 1: of Effect of treatment with a JAK2-selective inhibitor, fedratinib, on bone marrow fibrosis in patients with myelofibrosis

Year: 2015

Type: article

Abstract: Table S1. Changes in BMF according to baseline characteristics and clinical response.

Source: Figshare

DOI: 10.6084/m9.figshare.4472768

Authors: Jamieson, Catriona, Hasserjian, Robert, Gotlib, Jason, Cortes, Jorge, Stone, Richard, Talpaz, Moshe, Thiele, JĂźrgen, Rodig, Scott, Pozdnyakova, Olga

Language: English

Topic: Myeloproliferative Neoplasms: Diagnosis and Treatment

Subfield: Genetics (clinical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W7136051560

FWCI:

Cites:

Cited by:

Related to: 10